Citation: Fw. Chen et al., DIFFERENTIAL GENE-EXPRESSION IN APOPTOSIS - IDENTIFICATION OF RIBOSOMAL-PROTEIN 23K, A CELL-PROLIFERATION INHIBITOR, MOLECULAR GENETICS AND METABOLISM, 64(4), 1998, pp. 271-282
Citation: Fw. Chen et al., INVESTIGATION ON FOAM CERAMIC FILTER TO REMOVE INCLUSIONS IN REVERT SUPERALLOY, Materials letters, 34(3-6), 1998, pp. 372-376
Authors:
NARULA J
PETROV A
DITLOW C
PAK KY
CHEN FW
KHAW BA
Citation: J. Narula et al., MAXIMIZING RADIOTRACER DELIVERY TO EXPERIMENTAL ATHEROSCLEROTIC LESIONS WITH HIGH-DOSE, NEGATIVE CHARGE-MODIFIED Z2D3 ANTIBODY FOR IMMUNOSCINTIGRAPHIC TARGETING, Journal of nuclear cardiology, 4(3), 1997, pp. 226-233
Citation: Fw. Chen et al., APPLICATION OF STO BASIS-SETS TO THE FINITE-ELEMENT METHOD IN QUANTUM-CHEMISTRY, Progress in Natural Science, 7(4), 1997, pp. 450-456
Authors:
NARULA J
PETROV A
BIANCHI C
DITLOW CC
LISTER BC
DILLEY J
PIESLAK I
CHEN FW
TORCHILIN VP
KHAW BA
Citation: J. Narula et al., NONINVASIVE LOCALIZATION OF EXPERIMENTAL ATHEROSCLEROTIC LESIONS WITHMOUSE-HUMAN CHIMERIC Z2D3 F(AB')(2) SPECIFIC FOR THE PROLIFERATING SMOOTH-MUSCLE CELLS OF HUMAN ATHEROMA - IMAGING WITH CONVENTIONAL AND NEGATIVE CHARGE-MODIFIED ANTIBODY FRAGMENTS, Circulation, 92(3), 1995, pp. 474-484
Authors:
NARULA J
PETROV A
DITLOW C
DILLEY J
PIESLAK I
CHEN FW
KHAW BA
Citation: J. Narula et al., EARLIER EXPERIMENTAL ATHEROSCLEROTIC LESION VISUALIZATION WITH HIGH RADIOSPECIFIC-ACTIVITY, NEGATIVE CHARGE-MODIFIED CHIMERIC Z2D3 F(AB')(2) (AT 24 HOURS) VERSUS CONVENTIONALLY LABELED-ANTIBODY (AT 48 HOURS), The Journal of nuclear medicine, 35(5), 1994, pp. 160000098-160000098
Citation: Xx. Jiang et Fw. Chen, THE EFFECT OF LIPID PEROXIDES AND SUPEROXIDE-DISMUTASE ON SYSTEMIC LUPUS-ERYTHEMATOSUS - A PRELIMINARY-STUDY, Clinical immunology and immunopathology, 63(1), 1992, pp. 39-44